GGrantIndex
← Leaderboards

T Peter Kingham

Sloan-Kettering Inst Can Research

$2,940,023
Attributed
$6,578,403
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,294,935 · 8

By mechanism

UH3$2,258,511 · 1
R01$1,765,345 · 1
P20$1,343,162 · 4
D43$1,160,841 · 1
UG3$767,076 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Nigerian

Research focus

NigerianColorectal CancerNigeriaMalignant NeoplasmsCountryIncidenceDiagnosisResearch PersonnelProgramsBiobankRisk FactorsCollaborationsInfrastructureColon Cancer PatientsIncomeFutureResearch Project GrantsResourcesAfrica South Of The SaharaMemorial Sloan-Kettering Cancer CenterBiologyProspectiveMentorshipLow And Middle-Income Countries

Grant awards (25)

Expanding cancer research capacity in Nigeria with team science$268,483
D43 · FY2025 · CA · contact PI
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program$214,919
P20 · FY2025 · CA · contact PI
Research Project$133,690
P20 · FY2025 · CA · contact PI
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program$87,066
P20 · FY2025 · CA · contact PI
Administrative Core$81,229
P20 · FY2025 · CA · contact PI
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program$31,456
P20 · FY2025 · CA · contact PI
Admin-Core-001$28,620
P20 · FY2025 · CA · contact PI
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program$383,091
P20 · FY2024 · CA · contact PI
Expanding cancer research capacity in Nigeria with team science$269,094
D43 · FY2024 · CA · contact PI
Research Project$253,180
P20 · FY2024 · CA · contact PI
Administrative Core$129,911
P20 · FY2024 · CA · contact PI
Administrative supplement to expand cancer clinical trial capacity in sub-Saharan Africa$86,400
D43 · FY2024 · CA · contact PI
Determining the risk factor profile and biology of colorectal cancer in Nigeria$349,720
R01 · FY2023 · CA · contact PI
Expanding cancer research capacity in Nigeria with team science$268,073
D43 · FY2023 · CA · contact PI
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$740,348
UH3 · FY2022 · CA · contact PI
Determining the risk factor profile and biology of colorectal cancer in Nigeria$355,560
R01 · FY2022 · CA · contact PI
Expanding cancer research capacity in Nigeria with team science$268,791
D43 · FY2022 · CA · contact PI
Collecting whole genome sequence data to enhance the value of the first multi-center study of colorectal cancer risk factors and biology in Nigeria$195,604
R01 · FY2022 · CA
Mentoring a Nigerian junior investigator with a mixed-methods analysis of barriers to colorectal cancer presentation in Nigeria$124,999
R01 · FY2022 · CA · contact PI
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$751,117
UH3 · FY2021 · CA · contact PI
Determining the risk factor profile and biology of colorectal cancer in Nigeria$360,732
R01 · FY2021 · CA · contact PI
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$767,046
UH3 · FY2020 · CA · contact PI
Determining the risk factor profile and biology of colorectal cancer in Nigeria$378,730
R01 · FY2020 · CA · contact PI
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$361,263
UG3 · FY2018 · EB · contact PI
Point of care, real-time urine metabolomics test to diagnose colorectal cancers and polyps in low- and middle-income countries$405,813
UG3 · FY2017 · EB · contact PI